"New" bronchopulmonary dysplasia: A clinical review

Clinical Pulmonary Medicine

Volumn 18, Issue 3, 2011, Pages 137-143

  Bhandari, Anita ^a   Bhandari, Vineet ^b  

^a Division of Pediatric Infectious Diseases   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic lung disease; noninvasive ventilation; prematurity; pulmonary sequelae

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOSENTAN; CAFFEINE; CHLOROTHIAZIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; FUROSEMIDE; INFLUENZA VACCINE; PREDNISOLONE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RETINOL; SALBUTAMOL; SILDENAFIL; SPIRONOLACTONE; STEROID;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EXERCISE; FLUID THERAPY; HEREDITY; HUMAN; IMMUNIZATION; INFLUENZA; LUNG DYSPLASIA; LUNG FUNCTION; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PATHOGENESIS; PREMATURITY; PULMONARY HYPERTENSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SURVIVAL; THORAX RADIOGRAPHY;

EID: 79955819610     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/CPM.0b013e318218a071     Document Type: Article

References (79)

1. Baraldi E, Carraro S, Filippone M. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome. Early Hum Dev. 2009;85:S1-S3.
2. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196:147e141-147e148.
3. Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009;14:358-366.
4. Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116:1353-1360. (Pubitemid 46056482)
5. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:179-184. (Pubitemid 44062675)
6. Philip AG. Chronic lung disease of prematurity: a short history. Semin Fetal Neonatal Med. 2009;14:333-338.
7. Merritt TA, Deming DD, Boynton BR. The ?new? bronchopulmonary dysplasia: challenges and commentary. Semin Fetal Neonatal Med. 2009;14:345-357.
8. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946-1955. (Pubitemid 350074689)
9. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009;123:1562-1573.
10. Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117:1901-1906. (Pubitemid 46071232)
11. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics. 2008;122:479-485.
12. Bhandari V, Gruen JR. The genetics of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:185-191. (Pubitemid 44062676)
13. Thomson A, Bhandari V. Pulmonary biomarkers of bronchopulmonary dysplasia. Biomarker Insights. 2008;3:361-373.
14. Bhandari A, Bhandari V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci. 2003;8:e370-e380.
15. Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362: 1970-1979.
16. Bhandari V. Nasal intermittent positive pressure ventilation in the newborn: review of literature and evidence-based guidelines. J Perinatol. 2010;30:505-512.
17. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000;2:CD001456.
18. Kamlin CO, Davis PG. Long versus short inspiratory times in neonates receiving mechanical ventilation. Cochrane Database Syst Rev. 2004;4:CD004503.
19. Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112-2121. (Pubitemid 43736611)
20. Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357:1893-1902. (Pubitemid 350074685)
21. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1999;340:1962-1968.
22. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2003;1:CD001145
23. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2003;1:CD001144.
24. Bhandari A, Schramm CM, Kimble C, et al. Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia. Pediatrics. 2008;121:e344-e349. (Pubitemid 351198441)
25. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (
26. Bhandari A, Chow U, Hagadorn JI. Variability in duration of outpatient diuretic therapy in bronchopulmonary dysplasia: a clinical experience. Am J Perinatol. 2010;27:529-535.
27. Panitch HB, Keklikian EN, Motley RA, et al. Effect of altering smooth muscle tone on maximal expiratory flows in patients with tracheomalacia. Pediatr Pulmonol. 1990;9:170-176.
28. Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358:700-708. (Pubitemid 351240749)
29. Carlo WA, Finer NN, Walsh MC, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362: 1959-1969.
30. Bhandari A, Bhandari V. Bronchopulmonary dysplasia: an update. Indian J Pediatr. 2007;74:73-77. (Pubitemid 47305192)
31. Baveja R, Christou H. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:209-218. (Pubitemid 44062679)
32. Bhandari V, Brodsky N, Porat R. Improved outcome of extremely low birth weight infants with Tegaderm application to skin. J Perinatol. 2005;25:276-281. (Pubitemid 40515080)
33. Oh W, Poindexter BB, Perritt R, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147:786-790. (Pubitemid 41774834)
34. Lai NM, Rajadurai SV, Tan KH. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/ chronic lung disease. Cochrane Database Syst Rev. 2006;3: CD005093.
35. Ambalavanan N, Carlo WA. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:192-199. (Pubitemid 44062677)
36. Ng GY, da S, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2001;3:CD003214.
37. Furman L, Baley J, Borawski-Clark E, et al. Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease. J Pediatr. 1996;128:447-452. (Pubitemid 26114080)
38. Gross SJ, Iannuzzi DM, Kveselis DA, et al. Effect of preterm birth on pulmonary function at school age: a prospective controlled study. J Pediatr. 1998;133:188-192. (Pubitemid 28385193)
39. Northway WH Jr, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med. 1990; 323:1793-1799.
40. Halvorsen T, Skadberg BT, Eide GE, et al. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr. 2004;93:1294-1300. (Pubitemid 39273899)
41. Vrijlandt EJ, Gerritsen J, Boezen HM, et al. Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med. 2006;173:890-896.
42. Doyle LW, Casalaz D. Outcome at 14 years of extremely low birthweight infants: a regional study. Arch Dis Child Fetal Neonatal Ed. 2001;85:F159-F164. (Pubitemid 33701941)
43. Fakhoury KF, Sellers C, Smith EO, et al. Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia. Pediatrics. 2010;125:e1441-e1447.
44. Brostrom EB, Thunqvist P, Adenfelt G, et al. Obstructive lung disease in children with mild to severe BPD. Respir Med. 2010;104:362-370.
45. Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in extremely preterm children: The EPICure Study. Am J Respir Crit Care Med. 2010;182:237-245.
46. Hennessy EM, Bracewell MA, Wood N, et al. Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child. 2008;93:1037-1043.
47. Oppenheim C, Mamou-Mani T, Sayegh N, et al. Bronchopulmonary dysplasia: value of CT in identifying pulmonary sequelae. AJR Am J Roentgenol. 1994;163:169-172. (Pubitemid 24225709)
48. Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol. 2006;30:219-226. (Pubitemid 44062680)
49. Aquino SL, Schechter MS, Chiles C, et al. High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. AJR Am J Roentgenol. 1999;173:963-967. (Pubitemid 29451294)
50. Wong PM, Lees AN, Louw J, et al. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J. 2008;32:321-328.
51. Ochiai M, Hikino S, Yabuuchi H, et al. A new scoring system for computed tomography of the chest for assessing the clinical status of bronchopulmonary dysplasia. J Pediatr. 2008;152:90-95, 95e91-e93.
52. Aukland SM, Rosendahl K, Owens CM, et al. Neonatal bronchopulmonary dysplasia predicts abnormal pulmonary HRCT scans in long-term survivors of extreme preterm birth. Thorax. 2009;64: 405-410.
53. Aukland SM, Halvorsen T, Fosse KR, et al. High-resolution CT of the chest in children and young adults who were born prematurely: findings in a population-based study. AJR Am J Roentgenol. 2006;187:1012-1018. (Pubitemid 44453957)
54. Kairamkonda VR, Richardson J, Subhedar N, et al. Lung function measurement in prematurely born preschool children with and without chronic lung disease. J Perinatol. 2008;28:199-204. (Pubitemid 351338611)
55. Malmberg LP, Mieskonen S, Pelkonen A, et al. Lung function measured by the oscillometric method in prematurely born children with chronic lung disease. Eur Respir J. 2000;16:598-603.
56. Filippone M, Bonetto G, Cherubin E, et al. Childhood course of lung function in survivors of bronchopulmonary dysplasia. JAMA. 2009;302:1418-1420.
57. Stern DA, Morgan WJ, Halonen M, et al. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet. 2008;372:1058-1064.
58. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol. 2002;109:189-194. (Pubitemid 34158282)
59. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349:1414-1422. (Pubitemid 37211056)
60. Bader D, Ramos AD, Lew CD, et al. Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia. J Pediatr. 1987;110:693-699. (Pubitemid 17074734)
61. Hakulinen AL, Jarvenpaa AL, Turpeinen M, et al. Diffusing capacity of the lung in school-aged children born very preterm, with and without bronchopulmonary dysplasia. Pediatr Pulmonol. 1996;21:353-360. (Pubitemid 26239986)
62. Parat S, Moriette G, Delaperche MF, et al. Long-term pulmonary functional outcome of bronchopulmonary dysplasia and premature birth. Pediatr Pulmonol. 1995;20:289-296.
63. Jacob SV, Coates AL, Lands LC, et al. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr. 1998; 133:193-200. (Pubitemid 28385194)
64. Pianosi PT, Fisk M. Cardiopulmonary exercise performance in prematurely born children. Pediatr Res. 2000;47:653-658. (Pubitemid 30249855)
65. Andreasson B, Lindroth M, Mortensson W, et al. Lung function eight years after neonatal ventilation. Arch Dis Child. 1989;64:108-113.
66. Smith LJ, van Asperen PP, McKay KO, et al. Reduced exercise capacity in children born very preterm. Pediatrics. 2008;122: e287-e293.
67. Welsh L, Kirkby J, Lum S, et al. The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax. 2010;65:165-172.
68. Khemani E, McElhinney DB, Rhein L, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120:1260-1269. (Pubitemid 350223677)
69. Mourani PM, Sontag MK, Younoszai A, et al. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics. 2008;121:317-325. (Pubitemid 351198454)
70. Mourani PM, Sontag MK, Ivy DD, et al. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr. 2009;154:379-384, 384 e371-e372.
71. Krishnan U, Krishnan S, Gewitz M. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies. Pediatr Cardiol. 2008;29:1082-1086.
72. Bhandari V. Making babies breathe better: hopeful signals? Pediatr Res. 2008;64:123-124.
73. Bhandari V, Wang C, Rinder C, et al. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics. 2008;121:129-134.
74. Buhimschi CS, Bhandari V, Han YW, et al. Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis. 2009;22:235-243.
75. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med. 2010;15:223-229.
76. Schmidt HJ, Bhandari V, Bhandari A, et al. The future in paediatric respirology. Respirology. 2010;15:733-741.
77. Bourbon JR, Boucherat O, Boczkowski J, et al. Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets. Trends Mol Med. 2009;15:169-179.
78. Morty RE, Konigshoff M, Eickelberg O. Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6:607-613.
79. Hay WW Jr, Gitterman DP, Williams DA, et al. Child health research funding and policy: imperatives and investments for a healthier world. Pediatrics. 2010;125:1259-1265.